Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 68

1.

ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients.

Patnaik MM, Itzykson R, Lasho TL, Kosmider O, Finke CM, Hanson CA, Knudson RA, Ketterling RP, Tefferi A, Solary E.

Leukemia. 2014 Apr 3. doi: 10.1038/leu.2014.125. [Epub ahead of print]

PMID:
24695057
[PubMed - as supplied by publisher]
2.

CALR mutations are infrequent in WHO-defined refractory anemia with ring sideroblasts.

Patnaik MM, Belachew A, Finke C, Lasho TL, Hanson CA, Tefferi A.

Leukemia. 2014 Jun;28(6):1370-1. doi: 10.1038/leu.2014.47. Epub 2014 Jan 30. No abstract available.

PMID:
24476767
[PubMed - indexed for MEDLINE]
3.

Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review.

Patnaik MM, Parikh SA, Hanson CA, Tefferi A.

Br J Haematol. 2014 May;165(3):273-86. doi: 10.1111/bjh.12756. Epub 2014 Jan 28. Review.

PMID:
24467717
[PubMed - indexed for MEDLINE]
4.

Safety of pegfilgrastim (neulasta) in patients with sickle cell trait/anemia.

Kasi PM, Patnaik MM, Peethambaram PP.

Case Rep Hematol. 2013;2013:146938. doi: 10.1155/2013/146938. Epub 2013 Dec 11.

PMID:
24396616
[PubMed]
Free PMC Article
5.

Spontaneous coronary artery dissection during hematopoietic stem cell infusion.

Mir MA, Patnaik MM, Herrmann J.

Blood. 2013 Nov 7;122(19):3388-9. doi: 10.1182/blood-2013-09-528760. No abstract available.

PMID:
24203931
[PubMed - indexed for MEDLINE]
6.

In reply-dabigatran for heparin-induced thrombocytopenia.

Gonsalves WI, Pruthi RK, Patnaik MM.

Mayo Clin Proc. 2013 Sep;88(9):1036-7. doi: 10.1016/j.mayocp.2013.06.014. No abstract available.

PMID:
24001500
[PubMed - indexed for MEDLINE]
7.

Monosomal karyotype in Philadelphia chromosome-negative acute lymphoblastic leukemia.

Kenderian SS, Al-Kali A, Gangat N, Letendre L, Hogan WJ, Litzow MR, Patnaik MM.

Blood Cancer J. 2013 Jul 5;3:e122. doi: 10.1038/bcj.2013.21. No abstract available.

PMID:
23832069
[PubMed]
Free PMC Article
8.

Evaluation of revised IPSS cytogenetic risk stratification and prognostic impact of monosomal karyotype in 783 patients with primary myelodysplastic syndromes.

Gangat N, Patnaik MM, Begna K, Kourelis T, Knudson RA, Ketterling RP, Hodnefield JM, Hanson CA, Pardanani A, Tefferi A.

Am J Hematol. 2013 Aug;88(8):690-3. doi: 10.1002/ajh.23477. Epub 2013 Jun 20.

PMID:
23686868
[PubMed - indexed for MEDLINE]
9.

Visual loss in early-stage chronic lymphocytic leukemia.

Gonsalves WI, Zent CS, Pulido JS, Patnaik MM.

J Clin Oncol. 2013 Jun 10;31(17):e280-2. doi: 10.1200/JCO.2012.46.7431. Epub 2013 May 6. No abstract available.

PMID:
23650405
[PubMed - indexed for MEDLINE]
10.

The new oral anticoagulants in clinical practice.

Gonsalves WI, Pruthi RK, Patnaik MM.

Mayo Clin Proc. 2013 May;88(5):495-511. doi: 10.1016/j.mayocp.2013.03.006. Review. Erratum in: Mayo Clin Proc. 2013 Jul;88(7):777.

PMID:
23639500
[PubMed - indexed for MEDLINE]
11.

Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center.

Dispenzieri A, Seenithamby K, Lacy MQ, Kumar SK, Buadi FK, Hayman SR, Dingli D, Litzow MR, Gastineau DA, Inwards DJ, Micallef IN, Ansell SM, Johnston PB, Porrata LF, Patnaik MM, Hogan WJ, Gertz MA.

Bone Marrow Transplant. 2013 Oct;48(10):1302-7. doi: 10.1038/bmt.2013.53. Epub 2013 Apr 22. Review.

PMID:
23604010
[PubMed - indexed for MEDLINE]
12.

SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML.

Laborde RR, Patnaik MM, Lasho TL, Finke CM, Hanson CA, Knudson RA, Ketterling RP, Pardanani A, Tefferi A.

Leukemia. 2013 Oct;27(10):2100-2. doi: 10.1038/leu.2013.97. Epub 2013 Apr 5. No abstract available.

PMID:
23558523
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes.

Patnaik MM, Padron E, LaBorde RR, Lasho TL, Finke CM, Hanson CA, Hodnefield JM, Knudson RA, Ketterling RP, Al-kali A, Pardanani A, Ali NA, Komrokji RS, Tefferi A.

Leukemia. 2013 Jul;27(7):1504-10. doi: 10.1038/leu.2013.88. Epub 2013 Mar 27. Erratum in: Leukemia. 2013 Oct;27(10):2112. Komroji, R S [corrected to Komrokji, R S].

PMID:
23531518
[PubMed - indexed for MEDLINE]
14.

Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance.

Patnaik MM, Lasho TL, Finke CM, Hanson CA, Hodnefield JM, Knudson RA, Ketterling RP, Pardanani A, Tefferi A.

Am J Hematol. 2013 Mar;88(3):201-6. doi: 10.1002/ajh.23373. Epub 2013 Jan 18.

PMID:
23335386
[PubMed - indexed for MEDLINE]
15.

Correlation of screening and confirmatory results in tiered immunogenicity testing by solution-phase bridging assays.

Kubiak RJ, Zhang L, Zhang J, Zhu Y, Lee N, Weichold FF, Yang H, Abraham V, Akufongwe PF, Hewitt L, Robinson S, Liu W, Liu X, Patnaik MM, Spitz S, Wu Y, Roskos LK.

J Pharm Biomed Anal. 2013 Feb 23;74:235-45. doi: 10.1016/j.jpba.2012.10.027. Epub 2012 Nov 2.

PMID:
23245256
[PubMed - indexed for MEDLINE]
16.

Myeloid malignancy presenting with a platelet storage pool disorder.

Kourelis TV, Chen D, White JG, Gangat N, Uhl CB, Patnaik MM.

Leuk Lymphoma. 2013 Aug;54(8):1800-1. doi: 10.3109/10428194.2012.753448. Epub 2012 Dec 22. No abstract available.

PMID:
23185979
[PubMed - indexed for MEDLINE]
17.

Impact of lymphocyte and monocyte recovery on the outcomes of allogeneic hematopoietic SCT with fludarabine and melphalan conditioning.

DeCook LJ, Thoma M, Huneke T, Johnson ND, Wiegand RA, Patnaik MM, Litzow MR, Hogan WJ, Porrata LF, Holtan SG.

Bone Marrow Transplant. 2013 May;48(5):708-14. doi: 10.1038/bmt.2012.211. Epub 2012 Oct 29.

PMID:
23103674
[PubMed - indexed for MEDLINE]
18.

Comment on "Expansion of effector memory regulatory T cells represents a novel prognostic factor in lower risk myelodysplastic syndrome".

Gangat N, Patnaik MM.

J Immunol. 2012 Nov 1;189(9):4199; author reply 4199-200. doi: 10.4049/jimmunol.1290063. No abstract available.

PMID:
23087423
[PubMed - indexed for MEDLINE]
Free Article
19.

Secondary Epstein-Barr virus associated lymphoproliferative disorder developing in a patient with angioimmunoblastic T cell lymphoma on vorinostat.

Smeltzer JP, Viswanatha DS, Habermann TM, Patnaik MM.

Am J Hematol. 2012 Sep;87(9):927-8. doi: 10.1002/ajh.23271. Epub 2012 Jun 20.

PMID:
22718468
[PubMed - indexed for MEDLINE]
20.

Prognostic irrelevance of ring sideroblast percentage in World Health Organization-defined myelodysplastic syndromes without excess blasts.

Patnaik MM, Hanson CA, Sulai NH, Hodnefield JM, Knudson RA, Ketterling RP, Lasho TL, Tefferi A.

Blood. 2012 Jun 14;119(24):5674-7. doi: 10.1182/blood-2012-03-415356. Epub 2012 Apr 26.

PMID:
22538853
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk